1. Home
  2. HCWB vs UGRO Comparison

HCWB vs UGRO Comparison

Compare HCWB & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HCWB

HCW Biologics Inc.

HOLD

Current Price

$1.63

Market Cap

14.8M

Sector

Health Care

ML Signal

HOLD

Logo urban-gro Inc.

UGRO

urban-gro Inc.

HOLD

Current Price

$2.99

Market Cap

13.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCWB
UGRO
Founded
2018
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
14.8M
13.2M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
HCWB
UGRO
Price
$1.63
$2.99
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$35.00
N/A
AVG Volume (30 Days)
26.0M
72.1K
Earning Date
05-15-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.37
N/A
Revenue
$4,099,750.00
$17,399,438.00
Revenue This Year
N/A
$462.72
Revenue Next Year
N/A
$86.37
P/E Ratio
$4.41
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.25
$0.11
52 Week High
$7.35
$39.68

Technical Indicators

Market Signals
Indicator
HCWB
UGRO
Relative Strength Index (RSI) 53.32 30.66
Support Level $0.56 $2.13
Resistance Level $1.90 $3.41
Average True Range (ATR) 0.64 0.41
MACD -0.07 0.09
Stochastic Oscillator 21.10 6.03

Price Performance

Historical Comparison
HCWB
UGRO

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

About UGRO urban-gro Inc.

Urban-gro Inc operated as an integrated professional services and design-build firm offering architectural, engineering, and construction management solutions to the CEA, industrial, healthcare, and other commercial sectors. The company generated revenue by billing employees time on client projects and provided architectural, engineering, systems procurement and integration, and construction design-build solutions with a single point of accountability. For CEA clients, it developed indoor cultivation facilities for specialty crops, including cannabis and produce such as leafy greens, vegetables, herbs, and berries. Its segments included Equipment Systems (commercial horticulture equipment), Services (design-build services), and Construction Design-Build (general contracting).

Share on Social Networks: